Canada’s largest-ever investment in clinical trials announced by CIHR

Through the Clinical Trials Fund (CTF), The Canadian Institute of Health Research (CIHR) will support 22 research projects, 7 training platforms, and one 1 consortium. As part of Canada’s  Biomanufacturing and Life Sciences Strategy (BLSS), this investment now the largest investment Canada has ever received for clinic trial research.

The CIHR’s announcement provides exciting opportunities which could be pivotal in Canada’s clinical trial network, and show the importance of translational medicine work.  For example, the funding was mentioned in the public announcement as “foundational in ensuring that Canadians are well served by a national clinical trials network that fosters all aspects of therapeutics development, from discovery through to delivery.  It will be crucial to preparedness for future pandemics or other health emergencies and to grow a strong life sciences sector.” 

We recommend taking the time to learn more about the details and potential of the various initiatives and their funding allocations through the full announcement here, which features quotes from leaders in the field.